Fibromyalgia: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Fibrom Open Access 2:119,

The Role of Drug Efficacy Should be Downgraded in ICHD Diagnostic Criteria

Jiang H and Zhou J*
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, , Chongqing, China
*Corresponding Author : Zhou J, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1st You Yi Road, Yu Zhong District, Chongqing 400016, China, Tel: 023-89012558, Fax: 008602368811487, Email: zheadache@163.com

Received Date: Apr 24, 2017 / Accepted Date: May 13, 2017 / Published Date: May 19, 2017

Abstract

Headache is a highly complex condition and cannot be explained by a single mechanism. There are no biomarkers for headache, and no effective diagnostic tests which are universally applicable. For instance, the International Classification of Headache Disorders (ICHD) criteria for conditions such as chronic migraine, hemicrania continua and Tolosa-Hunt syndrome require diagnosis to include a detailed medical history and notification of potential sensitivity to treatment drugs.

However, diagnosis is flawed in some of these patients using the normal treatment criteria and can lead to incorrect diagnoses and treatment responses. This paper reviews relevant studies pertaining to treatment response to headache and suggests that the ICHD should remove treatment response as a criterion. The accurate diagnosis of headache must precede treatment, and consideration of drug efficacy should not be required as a diagnostic criterion for headache. We suggest that treatment response could help to confirm the final diagnosis of headache in cases where diagnosis is undefined, and it is entirely reasonable to downgrade the role of treatment response in the ICHD diagnostic criteria for headache.

Keywords: Treatment response; International classification of headache disorders; Chronic migraine; Hemicranias continua; Tolosa-Hunt syndrome

Citation: Jiang H, Zhou J (2017) The Role of Drug Efficacy Should be Downgraded in ICHD Diagnostic Criteria. Fibrom Open Access 2: 119.

Copyright: © 2017 Zhou J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top